bearish
Surveying The Biosimilar Battlefield
684 Views08 Sep 2017 10:35
The biosimilar market has been of particular interest to us in light of the high expectations set for Samsung Biologics Co., Ltd (207940 KS) and...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
- Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions28 Sep 2017
- Biosimilar Battlefield: Celltrion Forecasts24 Sep 2017
- Biosimilar Battlefield: Samsung Bioepis Forecast13 Sep 2017
- Surveying The Biosimilar Battlefield08 Sep 2017
- Celltrion Healthcare IPO Part 6 - IPO Bookbuilding Results17 Jul 2017
- Pass on the Deal, Put on the Watchlist27 Oct 2016
x